Published in Ann Surg Oncol on February 24, 2010
Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features. J Surg Oncol (2007) 0.92
T4 breast cancer under closer inspection: a case for revision of the TNM classification. Breast (2007) 0.91
Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann Surg Oncol (2008) 0.91
A new approach in breast cancer with non-inflammatory skin involvement. Acta Oncol (2006) 0.90
Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey. Ann Oncol (2005) 0.87
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med (2012) 4.10
Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Med Phys (2008) 2.84
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology (1991) 2.77
Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol (2009) 1.80
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (2000) 1.72
Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol (2008) 1.70
Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol (2007) 1.51
Whole breast lesion detection using naive bayes classifier for portable ultrasound. Ultrasound Med Biol (2012) 1.44
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer (2008) 1.44
Correlation of minimum coronary lumen diameter with left ventricular functional impairment induced by atrial pacing. Am J Cardiol (1988) 1.39
Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy. Philos Trans A Math Phys Eng Sci (2011) 1.38
Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study. Phys Med Biol (2007) 1.37
Endoscopic management of suspected esophageal foreign body in adults. Dis Esophagus (2010) 1.36
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology (2009) 1.34
Dependent pooling: a contrast-enhanced sign of cardiac arrest during CT. AJR Am J Roentgenol (2002) 1.27
Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox. J Clin Oncol (2008) 1.27
Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat (2003) 1.24
Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol (2009) 1.24
A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. Med Phys (2011) 1.23
Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med (1998) 1.22
Diagnosis of hepatic tumors with texture analysis in nonenhanced computed tomography images. Acad Radiol (2006) 1.15
Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol (2002) 1.15
MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging (2007) 1.13
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res (2009) 1.12
Multicentric aggressive angiomyolipomas: a rare form of PEComas. AJR Am J Roentgenol (2006) 1.12
Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res (2013) 1.09
Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol (2010) 1.09
A photo-multiplier tube-based hybrid MRI and frequency domain fluorescence tomography system for small animal imaging. Phys Med Biol (2011) 1.08
Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology (1994) 1.06
Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol Aging (1999) 1.06
Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys (2010) 1.05
Impact of skin removal on quantitative measurement of breast density using MRI. Med Phys (2010) 1.04
Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer (2009) 1.02
Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med (1994) 1.01
Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging (2007) 1.01
An integrative modeling approach to elucidate suction-feeding performance. J Exp Biol (2012) 1.00
Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys (2011) 0.99
Triple-negative breast cancer: MRI features in 29 patients. Ann Oncol (2007) 0.99
Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging (1999) 0.98
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology (2011) 0.97
Integrating the determinants of suction feeding performance in centrarchid fishes. J Exp Biol (2008) 0.97
Axial elongation in fishes: using morphological approaches to elucidate developmental mechanisms in studying body shape. Integr Comp Biol (2010) 0.96
Stereotypy, flexibility and coordination: key concepts in behavioral functional morphology. J Exp Biol (2008) 0.96
Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore. Technol Cancer Res Treat (2010) 0.96
Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys (2010) 0.96
Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol (2008) 0.96
The effects of random directional distributed flow in nuclear magnetic resonance imaging. Med Phys (1987) 0.95
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma. Gynecol Oncol (2005) 0.95
Urinary bladder metastasis from breast cancer with heterogeneic expression of estrogen and progesterone receptors. J Clin Oncol (2007) 0.95
Rapidly progressive pancreatic lipomatosis in a young adult patient with transfusion-dependent myelodysplastic syndrome. J Formos Med Assoc (2007) 0.93
Characterization of the veiling glare PSF in x-ray image intensified fluoroscopy. Med Phys (1984) 0.93
Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI. Magn Reson Imaging (2001) 0.93
Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med (1995) 0.93
Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat (2006) 0.93
Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. Radiology (2011) 0.92
Absolute cross-sectional area measurements in quantitative coronary arteriography by dual-energy DSA. Invest Radiol (1991) 0.92
Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed (2010) 0.92
Constrained iterative reconstruction by the conjugate gradient method. IEEE Trans Med Imaging (1985) 0.91
Homonuclear J-refocused spectral editing technique for quantification of glutamine and glutamate by 1H NMR spectroscopy. Magn Reson Med (1995) 0.91
Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan. Eur J Haematol (2003) 0.91
Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer. J Clin Oncol (2009) 0.91
Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann Surg Oncol (2008) 0.91
Emergent transcatheter arterial embolization in hemodynamically unstable patients with blunt splenic injury. Acad Radiol (2008) 0.91
Jaw protrusion enhances forces exerted on prey by suction feeding fishes. J R Soc Interface (2008) 0.90
Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging (2008) 0.90
Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer (2012) 0.89
Videodensitometric determination of minimum coronary artery luminal diameter before and after angioplasty. Am J Cardiol (1987) 0.89
MRI features of breast cancer: a correlation study with HER-2 receptor. Ann Oncol (2007) 0.89
Template-based automatic breast segmentation on MRI by excluding the chest region. Med Phys (2013) 0.88
Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol (2013) 0.87
Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg (2009) 0.87
Xanthogranulomatous pseudotumor of stomach induced by perforated peptic ulcer mimicking a stromal tumor. Eur Radiol (2006) 0.87
Hepatic steatosis and pancreatitis associated with the use of stavudine in a patient with HIV infection. AJR Am J Roentgenol (2004) 0.87
Digital subtraction angiography. Chest (1983) 0.87
Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.87
Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med (1996) 0.87
Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol (2008) 0.86
Quantitative analysis for breast density estimation in low dose chest CT scans. J Med Syst (2014) 0.86
A variable torque motor compatible with magnetic resonance imaging. Rev Sci Instrum (2009) 0.86
Comparative study of density analysis using automated whole breast ultrasound and MRI. Med Phys (2011) 0.86
Rapid image stitching and computer-aided detection for multipass automated breast ultrasound. Med Phys (2010) 0.86
Carryover effects alter FMRI statistical analysis in an acupuncture study. Am J Chin Med (2008) 0.85
Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI. Magn Reson Imaging (2013) 0.85
Removal of image intensifier veiling glare by mathematical deconvolution techniques. Med Phys (1985) 0.85
Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol (2009) 0.85
Digital coronary roadmapping as an aid for performing coronary angioplasty. Am J Cardiol (1985) 0.84
Computer-aided classification of breast masses using speckle features of automated breast ultrasound images. Med Phys (2012) 0.84
Computed tomographic imaging in determining the need of embolization for high-grade blunt renal injury. J Trauma Acute Care Surg (2013) 0.84